Screener
Olema Pharmaceuticals, Inc. OLMA Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development | $$49,232 | 30,624 |
| General and administrative | 8,754 | 4,249 |
| Total operating expenses | 57,986 | 34,873 |
| Loss from operations | (57,986) | (34,873) |
| Other income: | ||
| Interest income | 4,776 | 4,524 |
| Other income (loss) | 121 | (40) |
Item 1. Financial Statements.
FAQ
- What is Olema Pharmaceuticals, Inc.'s other operating expenses?
- Olema Pharmaceuticals, Inc. (OLMA) reported other operating expenses of $57.99M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s other operating expenses changed year-over-year?
- Olema Pharmaceuticals, Inc.'s other operating expenses increased by 66.3% year-over-year, from $34.87M to $57.99M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s other operating expenses has grown at a 25.7% compound annual growth rate (CAGR), from $71.49M to $178.7M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Olema Pharmaceuticals, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude